Product Program year 2025 Source: CMS Open Payments

Rhapsido

Drug Immunology

NDC 0078-1483-20

Open in the dashboard

General payments

$895,764

23,952 payments

Research payments

$12,705,634

479 payments

Through program year 2025, $895,764 in general payments and $12,705,634 in research payments were reported against Rhapsido (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $895,764 23,952
2025 Research $12,705,634 479

Breakdown

Who paid General payments · program year 2025
  1. Novartis Pharmaceuticals Corporation $895,764 23,952 payments
Top recipients General payments · program year 2025
  1. Russell Settipane Allergy & Immunology · Middletown, RI $24,218 3% · 27 payments
  2. Michael Blaiss Allergy & Immunology · Roswell, GA $22,131 2% · 23 payments
  3. Priya Bansal Allergy & Immunology · Saint Charles, IL $21,123 2% · 21 payments
  4. Naiem Issa Dermatology · Vienna, VA $19,224 2% · 22 payments
  5. Giselle Mosnaim Allergy & Immunology · Chicago, IL $13,487 2% · 14 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Dermatology $269,150 31% · 3,316 practitioners
  2. Allergy & Immunology $222,159 26% · 1,358 practitioners
  3. Physician Assistant $144,840 17% · 2,741 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $63,358 7% · 1,134 practitioners
  5. Physician Assistant, Medical Physician Assistant $39,296 5% · 734 practitioners

The top 5 of 80 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $91,529 10% · 1,128 recipients
  2. New York $67,510 8% · 1,025 recipients
  3. California $64,940 7% · 1,034 recipients
  4. Georgia $62,565 7% · 477 recipients
  5. Illinois $56,469 6% · 417 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

23,952 general · 479 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record